Senior insider sale
General Counsel at UROGEN PHARMA LTD. — senior position signals high conviction
$79.0K
4.99K shares
What this filing means
SMITH JASON DREW plans to sell 4.99K shares of UROGEN PHARMA LTD. valued at approximately $79.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/1/2024ACC: 0001976408-24-000031
Officer· General Counsel
Since Aug 2020
4.99K
Shares to sell
$79.0K
Approx. market value
30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Units
N/A
1/31/2023
20KRestricted Stock Units
N/A
1/31/2022
7.50KRestricted Stock Units
N/A
1/31/2021
2.50KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2023 | Restricted Stock Units N/A | 20K | — |
1/31/2022 | Restricted Stock Units N/A | 7.50K | — |
1/31/2021 | Restricted Stock Units N/A | 2.50K | — |
| Total | 30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.99K
Market value
$79.0K
1/31/2024
Total
Units
4.99K
Value
$79.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/31/2024 | 4.99K | $79.0K | NASDAQ | Planned |
| Total | 4.99K | $79.0K | ||